RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection
- PMID: 33975949
- PMCID: PMC8157936
- DOI: 10.1073/pnas.2025609118
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection
Conflict of interest statement
The authors declare no competing interest.
Comment in
-
Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience.Proc Natl Acad Sci U S A. 2022 Feb 15;119(7):e2103168119. doi: 10.1073/pnas.2103168119. Proc Natl Acad Sci U S A. 2022. PMID: 35131936 Free PMC article. No abstract available.
Dataset described in
-
A data-driven approach to identify risk profiles and protective drugs in COVID-19.Proc Natl Acad Sci U S A. 2021 Jan 7;118(1):e2016877118. doi: 10.1073/pnas.2016877118. Epub 2020 Dec 10. Proc Natl Acad Sci U S A. 2021. PMID: 33303654 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous